Infinium Pharmachem Inks 5-Year Japan Deal with K Sakai & Co.—Eyes Global Iodine Expansion

Infinium Pharmachem Ltd., a leading manufacturer of iodine derivatives, has signed a 5-year exclusive distribution agreement with K Sakai & Company Ltd., a prominent Japanese trading firm. The partnership aims to expand Infinium’s footprint in Japan, one of the world’s most quality-conscious pharmaceutical and specialty chemical markets.

 

The agreement grants K Sakai exclusive rights to distribute Infinium’s iodine-based compounds and APIs across Japan, reinforcing Infinium’s strategy to deepen global market penetration and leverage local expertise. With over 200 iodine derivatives and 15+ APIs in its portfolio, Infinium is already a key supplier to pharma, biotech, and specialty chemical industries worldwide.

 

This move aligns with Infinium’s broader vision to become a preferred global partner in iodine chemistry, backed by its GMP-compliant, FDA-approved facility in Gujarat, India.

 

Key Highlights:

Source: Infinium Pharmachem Official Website